EMT-mediated regulation of CXCL1/5 for resistance to anti-EGFR therapy in colorectal cancer

YL Park, HP Kim, CY Ock, DW Min, JK Kang, YJ Lim… - Oncogene, 2022 - nature.com
The emergence of RAS/RAF mutant clone is the main feature of EGFR inhibitor resistance in
KRAS wild-type colon cancer. However, its molecular mechanism is thought to be …

The multiplex bead array approach to identifying serum biomarkers associated with breast cancer

BK Kim, JW Lee, PJ Park, YS Shin, WY Lee… - Breast Cancer …, 2009 - Springer
Introduction Breast cancer is the most common type of cancer seen in women in western
countries. Thus, diagnostic modalities sensitive to early-stage breast cancer are needed …

Electrochemical nanobiosensing in whole blood: Recent advances

M Hasanzadeh, N Shadjou - TrAC Trends in Analytical Chemistry, 2016 - Elsevier
Currently, the assay of whole blood has emerged as an important tool in modern biomedical
research such as clinical diagnostics, drug discovery, and biodefense. Whole blood is a …

Rapid, label-free, electrical whole blood bioassay based on nanobiosensor systems

HK Chang, FN Ishikawa, R Zhang, R Datar, RJ Cote… - ACS …, 2011 - ACS Publications
Biomarker detection based on nanowire biosensors has attracted a significant amount of
research effort in recent years. However, only very limited research work has been directed …

[HTML][HTML] Another review on triple negative breast cancer. Are we on the right way towards the exit from the labyrinth?

R Chiorean, C Braicu, I Berindan-Neagoe - The Breast, 2013 - Elsevier
Triple negative breast cancer is a heterogeneous group of tumors, lacking the expression of
estrogen, progesterone and HER-2 receptors. As frequency, it accounts about 15–20% of all …

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast …

S Ohno, LWC Chow, N Sato, N Masuda… - Breast cancer research …, 2013 - Springer
This randomized, multicenter study compared the efficacy of docetaxel with or without
capecitabine following fluorouracil/epirubicin/cyclophosphamide (FEC) therapy in operable …

Apoptosis markers in breast cancer therapy

CY Kadam, SA Abhang - Advances in clinical chemistry, 2016 - Elsevier
Cancer is a disease characterized by a very little apoptosis, ie, genetically programmed cell
death. Aberrations in apoptotic pathways are central to tumorigenesis, tumor progression …

Predictive and prognostic value of Matrix metalloproteinase (MMP)-9 in neoadjuvant chemotherapy for triple-negative breast cancer patients

RX Wang, S Chen, L Huang, ZM Shao - BMC cancer, 2018 - Springer
Background This study aimed to investigate the clinical utility of serum and histological MMP-
9 detection during neoadjuvant chemotherapy (NAC) for triple-negative breast cancer …

Serum biomarker panels for the diagnosis of gastric adenocarcinoma

HS Ahn, YS Shin, PJ Park, KN Kang, Y Kim… - British journal of …, 2012 - nature.com
Background: Currently, serum biomarkers, which are sufficiently sensitive and specific for
early detection and risk classification of gastric adenocarcinoma do not exist. Therefore, this …

Different Patterns of Cytokines and Chemokines Combined with IFN-γ Production Reflect Mycobacterium tuberculosis Infection and Disease

Y Yu, Y Zhang, S Hu, D Jin, X Chen, Q Jin, H Liu - 2012 - journals.plos.org
Background IFN-γ is presently the only soluble immunological marker used to help diagnose
latent Mycobacterium tuberculosis (M. tb) infection. However, IFN-γ is not available to …